美国风湿病学会关于应对儿童风湿病患儿心理健康问题的指导声明
该指导声明由美国风湿病学会(ACR)工作组制定,旨在帮助儿童风湿科团队识别和管理患儿的焦虑抑郁等心理健康问题。工作组起草34条声明,经76名儿童关节炎与风湿病研究联盟成员两轮德尔菲投票,31条达成至少80%共识,其中11条获高实证支持并被ACR认可为最终指导声明。
要点
- 建议对12岁及以上风湿病患儿进行抑郁和焦虑筛查。
- 指导声明涵盖识别、管理及诊所环境与教育方面的考虑。
- 最终11条声明获ACR认可,基于高实证支持。
核心结论
- 目标是这些推荐能帮助儿童风湿科团队更好地应对其环境中的心理健康问题,并改善风湿病患儿的心理健康及健康相关结局。
研究设计与样本
- 指导声明制定于2019年启动,2023年11月完成。
- 工作组包括儿童风湿科医生、儿童行为健康提供者、患者和家长,由两名持证儿童心理学家和两名委员会认证的儿童风湿科医生领导。
- 方法包括迭代起草声明、基于牛津循证医学中心证据等级评定证据、开放评论期后修订、德尔菲专家组达成共识,以及ACR医疗质量委员会审查并精炼出高实证支持声明列表。
- 德尔菲投票由儿童关节炎与风湿病研究联盟76名成员的随机样本进行两轮投票。
主要发现
- 工作组起草了34条应对儿童风湿科心理健康问题的声明,包括识别、管理和诊所环境/教育考虑。
- 两轮德尔菲投票后,31条声明达成至少80%共识。
- 其中11条声明具有高实证支持和认可,被选为最终指导声明。
关键数值与推荐
- 最终11条指导声明包括建议对12岁及以上患儿进行抑郁和焦虑筛查、管理已识别症状以及患者心理健康教育。
- 31条声明达成至少80%共识。
- 11条声明具有高实证支持并获认可。
临床怎么用
- 这些推荐旨在帮助儿童风湿科团队考虑如何在其环境中更好地应对心理健康问题。
- 原文未据此给出其他具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pediatric rheumatologic diseases (PRDs) are characterized by high rates of anxiety and depression known to impact health-related outcomes. We present guidance statements to assess and manage mental health concerns for youth with PRDs in pediatric rheumatology practice. METHODS: Development of the guidance statements was initiated in 2019 and concluded in November 2023. It included (1) the formation of a task force (including pediatric rheumatologists, pediatric behavioral health providers, patients, and parents) led by two licensed pediatric psychologists and two board-certified pediatric rheumatologists, (2) iterative drafting of statements and rating of evidence based on the Oxford Centre for Evidence-Based Medicine levels of evidence, (3) an open comment period followed by revision of statements, (4) a Delphi panel process to attain consensus on the statements, and (5) review by the American College of Rheumatology (ACR) Committee on Quality of Care and refinement of statements to an identified list of those with the strongest empiric evidence for endorsement by the ACR. RESULTS: The task force drafted 34 statements for addressing mental health concerns in pediatric rheumatology, including identification, management, and clinic environment/education considerations. After two rounds of Delphi panel voting by a random sample of 76 members of the Childhood Arthritis and Rheumatology Research Alliance, 31 statements attained at least 80% consensus. Eleven of those statements had high empirical support and endorsement and were thus selected as the final guidance statements, including recommendations for depression and anxiety screening in youth aged 12 years and older, management of identified symptoms, and education of patients about mental health. CONCLUSION: It is a goal that these recommendations be used to empower pediatric rheumatology teams to consider how they may better address mental health concerns in their setting and help improve both mental health- and health-related outcomes for youth with rheumatologic diseases.
引用
- Cunningham NR, Danguecan AN, Ely SL, et al. American College of Rheumatology Guidance Statements for Addressing Mental Health Concerns in Youth With Pediatric Rheumatologic Diseases. Arthritis Care Res (Hoboken). 2025. PMID: 40051122. doi:10.1002/acr.25519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。